Sale!

FGFR2 Gene Craniofacial-Skeletal-Dermatologic Dysplasia Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The FGFR2 Gene Craniofacial-Skeletal-Dermatologic Dysplasia Genetic Test is a sophisticated diagnostic tool offered by DNA Labs UAE, designed to detect mutations in the FGFR2 gene. These mutations are known to cause a range of developmental disorders affecting the craniofacial structure, skeletal system, and skin. The FGFR2 gene plays a crucial role in cell division, growth, and repair, and abnormalities within this gene can lead to various syndromes, including Apert Syndrome, Crouzon Syndrome, and Pfeiffer Syndrome, among others. These conditions are characterized by premature fusion of skull bones, abnormalities in the hands and feet, and a range of dermatologic and skeletal issues.

The test is conducted using a sample of the patient’s DNA, extracted from a blood sample or cheek swab, and employs state-of-the-art genetic sequencing technology to identify mutations in the FGFR2 gene. This precise diagnostic approach allows for early detection and a better understanding of the condition, facilitating tailored treatment and management plans for affected individuals.

Priced at 4400 AED, the FGFR2 Gene Craniofacial-Skeletal-Dermatologic Dysplasia Genetic Test is a valuable resource for families and individuals seeking clarity on genetic conditions affecting craniofacial, skeletal, and skin health. DNA Labs UAE is committed to providing accurate, comprehensive genetic testing services to help improve the lives of those dealing with genetic disorders.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

FGFR2 Gene Craniofacial-skeletal-dermatologic dysplasia Genetic Test

Welcome to DNA Labs UAE, where we offer the FGFR2 Gene Craniofacial-skeletal-dermatologic dysplasia Genetic Test. This test is designed to provide valuable insights into the genetic factors associated with craniofacial-skeletal-dermatologic dysplasia, a rare genetic disorder.

Test Details

The FGFR2 gene plays a crucial role in the development and maintenance of various tissues in the body, including the craniofacial, skeletal, and dermatologic tissues. Craniofacial-skeletal-dermatologic dysplasia is a genetic disorder caused by mutations in the FGFR2 gene. It affects the development of craniofacial bones, leading to abnormalities such as a prominent forehead, wide-set eyes, and a beaked nose. It also affects skeletal and dermatologic tissues, resulting in abnormal bone growth, fusion, and thickened, scaly skin.

Test Components and Price

The FGFR2 Gene Craniofacial-skeletal-dermatologic dysplasia Genetic Test is priced at 4400.0 AED. The test requires a blood sample, extracted DNA, or one drop of blood on an FTA card.

Report Delivery and Method

After the sample is collected, the report will be delivered within 3 to 4 weeks. The test utilizes NGS (Next-Generation Sequencing) technology, allowing for the simultaneous analysis of multiple genes or even the entire genome.

Test Type and Doctor

The FGFR2 Gene Craniofacial-skeletal-dermatologic dysplasia Genetic Test falls under the categories of osteology, dermatology, and immunology disorders. It is recommended to consult with a dermatologist for this test.

Pre Test Information

Prior to undergoing the FGFR2 Gene Craniofacial-skeletal-dermatologic dysplasia NGS Genetic DNA Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by FGFR2 Gene Craniofacial-skeletal-dermatologic dysplasia.

Conclusion

The FGFR2 Gene Craniofacial-skeletal-dermatologic dysplasia Genetic Test offered by DNA Labs UAE is a valuable tool for diagnosing this rare genetic disorder. NGS genetic testing allows for the identification of mutations in the FGFR2 gene, providing important information about the condition’s severity and guiding treatment options. If you suspect craniofacial-skeletal-dermatologic dysplasia, consult with a dermatologist and consider undergoing this genetic test for a comprehensive evaluation.

Test Name FGFR2 Gene Craniofacial-skeletal-dermatologic dysplasia Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Osteology Dermatology Immunology Disorders
Doctor Dermatologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for FGFR2 Gene Craniofacial-skeletal-dermatologic dysplasia NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with FGFR2 Gene Craniofacial-skeletal-dermatologic dysplasia NGS Genetic DNA Test gene FGFR2
Test Details

The FGFR2 gene is a gene that provides instructions for making a protein called fibroblast growth factor receptor 2. This protein is involved in the development and maintenance of various tissues in the body, including the craniofacial (head and face), skeletal (bones), and dermatologic (skin) tissues.

Craniofacial-skeletal-dermatologic dysplasia is a rare genetic disorder that is caused by mutations in the FGFR2 gene. This condition affects the development of the craniofacial bones and leads to various craniofacial abnormalities, such as a prominent forehead, wide-set eyes, and a beaked nose. It can also cause skeletal abnormalities, including abnormal bone growth and fusion, as well as dermatologic abnormalities, such as thickened and scaly skin.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that allows for the simultaneous analysis of multiple genes or even the entire genome. In the context of FGFR2 gene craniofacial-skeletal-dermatologic dysplasia, NGS genetic testing can be used to identify mutations or changes in the FGFR2 gene that are responsible for the disorder. This can help with the diagnosis of the condition and may also provide information about the specific mutation present, which can be helpful for determining the severity of the condition and guiding treatment options.